Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.
The Royal College of Veterinary Surgeons Charitable Trust has awarded five new bursaries in its latest grants round.
Two student bursaries were for UK veterinary undergraduates to attend the British Science Festival in Aberdeen from 4-9 September 2012. The bursary winners were Liv Nathan (pictured on right), a third-year veterinary student at the Royal Dick School of Veterinary Studies, and Alahel Mahdmina, a second-year veterinary student at the Royal Veterinary College.
Liv said: "I am very enthusiastic about providing real-life context to science and giving people a space to consider issues arising around science."
The students were required to use their observations and experiences to help the Trust develop future outreach activities to inform and inspire public audiences about veterinary clinical practice and research. Their bursary packages covered all their attendance expenses over the four-day event. One of their achievements was to film an interview with Dr Maggie Aderin-Pockock MBE, a space scientist (pictured on left). Both students will be reporting back in full to the RCVS Charitable Trust with their ideas at the end of October.
Two further bursaries were given to attend a joint symposium on antimicrobial resistance (AMR): 'Antimicrobial Resistance in Human and Veterinary Medicine - One Health, One Problem' to be held at the Royal College of Physicians, London, on Tuesday 2 October 2012.
One winner was Cahir King, a practitioner from Downe Veterinary Clinic in County Down, Northern Ireland. He said: "It will be a privilege to attend a symposium at which so many experts in their field will be speaking. Any vet who has worked on farms will be more than familiar with bugs that are resistant to antibiotic treatment."
The other winner was James Swann, a Junior Clinical Training Scholar (Small Animal) at the Royal Veterinary College. James said: "I am particularly interested in the application of clinical audit in practice to assess problems like AMR, and design effective strategies to deal with them. I believe it should be possible to provide simple audit kits for practices to download and implement, removing much of the inertia that prevents such ideas from being initiated."
The bursary winners will be offered free delegate passes, including lunch, worth £90, and travel expenses.
The final bursary is to attend the Veterinary Biomedical and Pharma Sciences (VBMPS) Congress on 15-16 October, in Birmingham.
The winning entry was from Alexander Stoll, a final-year student at the Royal Veterinary College, who acted as the Royal Veterinary College and UK student ambassador to the European Commission for the 'One Health' message. The Trust was impressed with Alexander's enthusiasm and active engagement in subjects related to One Health. He is a member of the Royal Society for Public Health and a member of the Society of Biology.
Alexander said: "I hope to be inspired to enter a cross-disciplinary career path and also to communicate the potential of a One Health approach, inspired by this congress."
Alexander won a package that includes entry to the conference and admission to all scientific sessions, worth £175, as well as transport costs and overnight food and accommodation.
The University of Surrey has announced that it is to launch a new school of veterinary medicine in 2014.
According to the University, the new school will embrace the 'One Health - One Medicine' philosophy and will include the development of a unique research-led veterinary medicine degree programme with an emphasis on research, veterinary pathology and livestock medicine.
The new school will be based at the University of Surrey's Manor Park site in Guildford, in order to encourage collaboration of students and staff from different disciplines, with those studying towards a veterinary medicine qualification being exposed to engineering and physics as well as receiving training in core business skills.
The new School of Veterinary Medicine at Surrey will be delivered through collaborations with key partners including: the Animal Health and Veterinary Laboratories Agency (AHVLA), the BBSRC Pirbright Institute, the Veterinary Medicines Directorate (VMD), Fitzpatrick Referrals, Liphook Equine Hospital and Westpoint Farm Vets. The University says it is looking to extend its relationships with regional veterinary practices over the coming year.
Students will also be exposed to global issues concerning animal health through the University Global Partnership Network (UGPN), a trilateral agreement between Surrey, North Carolina State and São Paulo Universities through teaching collaborations, summer scholarships and research exchanges.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: "As a research-intensive University we have the expertise, reputation, technical and business skills which our students can benefit from, allowing us to train the veterinary leaders of the future. Combining state-of-the-art facilities, our unique partnerships and a campus location, the new School will provide a stimulating environment not only for undergraduates, but for the professional development training of qualified veterinary surgeons."
Professor John Fazakerley, Director of The Pirbright Institute, said: "This is good news for the UK veterinary research community. The Pirbright Institute currently works in close collaboration with the University of Surrey on research that benefits animal health and welfare; we very much look forward to building on this established and growing association as the new school of veterinary medicine is launched. There is an important place for trained veterinarians in scientific research and we are delighted that the University has decided to emphasise these areas in particular."
Professor Andy Durham of the Liphook Equine Hospital said: "The new School of Veterinary Medicine development programme at the University of Surrey is ideally timed to provide an alternative to the traditional veterinary education and to respond to the demands of a changing profession with fresh plans, ideas and enthusiasm. Enticing newly developed facilities make Guildford an excellent student town and with several collaborative specialist partners within the locality the new School of Veterinary Medicine is perfectly placed geographically to provide a veterinary education fitting for the 21st century."
The University is also in consultation with the Royal College of Veterinary Surgeons. Freda Andrews, Head of Education at the RCVS, said: "We were pleased to meet Professor Sir Christopher Snowden, President and Vice-Chancellor and his colleagues from the University of Surrey recently, and interested to hear their proposals to develop a new School of Veterinary Medicine. We will be working with them over the coming months to develop a timetable for considering the new programme against our accreditation standards. The monitoring process will take a number of years."
The University says it has already laid the foundations for the new School through its expansion of teaching and research activities in its Faculty of Health and Medical Sciences, including the launch of the BSc programme in Veterinary Biosciences in 2009 and in October of this year a new MSc in Veterinary Microbiology. A new MSc in Veterinary Pathology is also currently under development.
The University says that over the next 12 months it will be recruiting new academic staff, attracting the first cohort of students and beginning building works in preparation for the first cohort of students in 2014.
Companion Care Vets has announced it will work in partnership with VetAbroad, an e-learning company that has been established to help vets who qualified outside the UK to develop a successful career within it.
Companion Care is the first veterinary group in the UK to enter into partnership with VetAbroad, with the aim that all new non-UK employees will complete the course.
According to the company, almost 30% of vets registered in the UK are from overseas and statistics show that one in three will leave the register in less than 24 months and 20% in less than 12 months. Statistics also highlight the likelihood of a non-UK vet to be struck off or suspended is six times higher than for a UK vet.
Jane Balmain, Managing Director of Companion Care Vets said: "Whilst we as a company offer as much support as possible to our team members from overseas and support their continued learning , we are delighted to be working in partnership with VetAbroad to utilise their training solutions and further enhance what we offer to team members who come from overseas. All new employees will be required to take the course and we will also be encouraging our current overseas vets to complete it."
The e-course covers social and professional adaptation, compliance with current legislation, teamwork, productivity, client care and communication skills and VetAbroad states that those taking the course will substantially increase their chances of retaining and obtaining a job in the UK.
Vet and founder of VetAbroad Luis Sainz-Pardos said: "The primary aim of our course is to help vets who have qualified overseas to swiftly integrate into the UK system. Vets who have taken the course will be aware of UK legislation and should be able to interact with colleagues, clients and patients to a UK standard. As a result, the problems often associated with employing non-UK vets to work in UK practices are greatly reduced. I am thrilled to be working in partnership with Companion Care Vets, a company that I believe is thriving due to its investment in its most important asset - people."
For further information about VetAbroad please visit www.vetabroad.com
Phil Kenward from Farm Vets South West in Bridgewater, Somerset has won a bottle of port from the Veterinary Benevolent Fund for submitting the best practical veterinary tip.
The tip was:
"Do not allow the owner's diagnosis of his problem to worry or influence you before you examine the animal yourself."
The competition was run to celebrate the launch of The Pocket Book of Tips For Practising Vets which can be ordered on-line from the Vetlife website to raise funds for the VBF charity.
Lydia Brown, President of the VBF, said: "This book has been a monumental effort by six mixed practice vets, to both share their experience with the profession and to provide very welcome funds for the veterinary profession's own charity, the VBF. We are currently raising money for the new Vet Helpline e-mail support service which will launch at the end of the year so we are extremely grateful to everybody concerned for all their efforts."
A lecturer of special eminence in veterinary anatomy is sought for the 2013 RCVS Share Jones Lectureship.
This is a biennial award whose recipients give a public lecture on a subject agreed with the College.
Recent lectures have included 'Who says you can't be big and nimble? The fragility of giant land animals,' given in 2011 by Professor John Hutchinson, whose expertise includes the anatomy and locomotion of dinosaurs and crocodiles; and 'Sex and Regeneration: Lessons from Nature,' a study of deer antlers presented by Professor Jo Price.
Jo said: "It was a great privilege to be asked to deliver the Share Jones Lecture and it was an experience that I will remember as one of the highlights of my career. This lecture provides a unique opportunity for those of us with a deep interest in structure-function relationships to showcase the discipline of veterinary anatomy and inspire the next generation of veterinary scientists."
Any lecturer who has achieved special eminence in veterinary anatomy is eligible for nomination; RCVS membership is not a requirement. Nominations will be considered by the Education Policy and Specialisation Committee in February, with decisions made by RCVS Council in March. To nominate a candidate for the lectureship, please email his or her CV, with a letter of recommendation, to Ms Anne Jermey (education@rcvs.org.uk).
The Veterinary Marketing Association has announced a Practice Marketing Award, with a prize of £500 worth of CPD, for which entries are now being sought.
The award, which is sponsored by Merial, is open to companion and farm animal practices that can demonstrate effective marketing to their clients during the course of 2012.
For more information, visit: www.vma.org.uk/awards, or email: secretary@vma.org.uk for entry details.
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
Petplan has launched a video to promote its Veterinary Awards to the public.
Impressively, it has already notched up over 57,000 views on youtube.
Ceva Animal Health has announced that it is now accepting nominations for its annual Animal Welfare Awards.
The awards recognise veterinary surgeons, veterinary nurses and charity professionals who go the extra mile to prevent and reduce welfare problems for animals.
If you think one of your colleagues, vet or nurse, should be recognised for their work improving animal welfare, you'll need to nominate them before the 15th February 2013 deadline.
The awards include:
Winners of all awards will have a choice of luxury prize - ranging from spa weekends, European city breaks, countryside retreats or an animal experience. All individuals who nominate will be automatically entered into a prize draw to win £250 of high street vouchers. Ginette Bryant from Ceva, said: "The Ceva Animal Welfare Awards are an opportunity to recognise the hard work and dedication of individuals in the veterinary and animal charity industry. Our mission 'Together, beyond animal health', recognises that the health of animals, humans and the planet are inextricably linked, these awards are fitting way to work towards improving the health of all. "Whether it is improving animal welfare through client education in practice, championing good causes or helping specific cases, we know there are many people who share our ambitions in preventing and reducing companion animal welfare issues. It is these passionate individuals who are the unsung heroes of our industry and we're really excited to hear the inspiring stories from each nomination."
There are also three awards for people who work outside the veterinary or animal charity sector.
Nominations forms are available from www.ceva.com.
The deadline for entries is 15 February 2013.
For further details or additional nomination forms for your practice call Ceva on 01494 781 510 or email welfare.awards@ceva.com The awards ceremony will be held on Wednesday 3 April 2013 during the BSAVA conference in Birmingham.
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
The RCVS has launched a survey to discover what the profession thinks it does well and what it could improve upon.
The confidential online survey asks about your recent interactions with the College, what you think the organisation does well and what can be improved upon.
The survey is one of several activities that the College is undertaking as part of its First-Rate Regulator initiative. Others include a survey amongst those who have made complaints; research amongst RCVS staff and Council / VN Council members; in-depth phone interviews with veterinary surgeons, veterinary nurses and practice managers; and, questionnaires aimed at stakeholder organisations that work regularly with the College.
Desk-based research is also being carried out, to see how the RCVS shapes up when compared to other similar regulators, both in the UK and overseas.
Following this evidence-gathering stage, an assessment will be made about where gaps exist between how the College performs and what it ought to be achieving, together with recommendations for change.
Nick Stace, RCVS CEO said: "Becoming a first-rate regulator is the aim, building on the good things we do, and challenging ourselves to be better where we fall short."
"Although the RCVS has a long and proud history, we also need to have a sustainable future. Careful scrutiny of what we do, and how we can improve, will ensure this. I would urge all members of the veterinary team to take this unique opportunity to help improve the regulation of their professions."
The survey closes on 4 January 2013. All veterinary surgeons and veterinary nurses for whom the RCVS holds unique email addresses will be sent a link to the survey. Others are invited to visit www.rcvs.org.uk/firstratesurvey to take part. Practice managers, and student vets and VNs are also encouraged to complete the survey. Individuals who are not veterinary surgeons, nurses, students or practice managers, and who have views about how the College could improve, are invited to contact Nick Stace on nick@rcvs.org.uk.
BCF Technology has announced the launch of the Logiq S7 Expert ultrasound system.
BCF says the new system offers the latest in ultrasound technology and represents a significant leap forward in imaging capability.
The Logiq S7 ultrasound system includes features such as B-Flow, Elastography, Flow Quantification, Contrast Imaging, B-Steer+, 3D/4D ultrasound, Volume Imaging and Multi-Modality Imaging Display.
Nigel Perry from BCF said: "The new Logiq S7 Expert provides the highest image quality currently available in the market. With a wide range of probes available for every veterinary application. If you are looking for the ultimate in ultrasound capability then the Logiq S7 is the system for you."
For more information, visit http://www.bcftechnology.co.uk/ or call +44(0)1506 460 023.
Bayer Animal Health has produced a take home prescription guide to encourage pet owners to remain compliant with its antimicrobial, Veraflox (pradofloxacin).
The leaflet contains prescription details together with a treatment record and next appointment reminder. Group Product Manager Tracey Dawson said: "There is also a FAQ (frequently asked questions) section explaining why compliance is so important."
Bayer says the leaflet has been developed to help vets and VNs ensure pet owners are encouraged to be responsible with prescribed medicines. Tracey added: "The guide is designed to reinforce the information given by the prescribing vet, and answer further questions owners might have on arrival home or during the treatment."
Bayer highlights that Veraflox's mode of action helps reduce the potential for the development of resistant bacteria¹, but only if it is used correctly. Tracey said: "Although it might seem to be easy for pet owners to adhere to the advice given with prescribed medicines, especially with the more palatable options now available, it is very important that we help preserve the efficacy of the fluoroquinolone class by continuing to encourage strict client compliance through correct dosing, and finishing the course of antibiotics prescribed."
For further information, contact your Bayer Territory Manager or call Bayer Animal Health on 01635 563000.
Reference
Wetzstein HG. Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance. Antimicrob Agents Chemother. 2005;49(10): 4166-4173
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
Petplan has announced that nominations are now open for its 14th annual Veterinary Awards.
The awards recognise members of the veterinary community who have gone above and beyond in their daily role.
According to the company, one in three pets make an unexpected trip to the vet each year, making vets the unofficial 4th emergency service. A quarter of pet owners consider their vet a good friend with 42% on first name terms. 98% of Petplan customers have said that they trust their vet; with many saying that they are more trustworthy than police officers - coming second only to doctors.
Petplan's Head of Marketing, Isabella Von Mesterhazy said: "At Petplan, we hear from our customers every day about the exceptional service veterinary staff have given to pets in their care. The Veterinary Awards are an opportunity for Petplan to show our support to members of this profession and thank these hard-working individuals on a national scale. We want to encourage pet owners across the UK to nominate their veterinary stars this year to show their appreciation for all their tireless effort to keep the nations pets fit and healthy."
To make nominate a vet, vet nurse, vet practice and other members of the veterinary team visit www.petplan.co.uk/vetawards before 31st January 2013. The winners will be announced at the ceremony held in Birmingham on 4th April 2013.
Virbac has published a compendium of recent independently-published studies relating to its range of dermatology products.
Studies are listed according to the disorders investigated with an impact rating given to each piece of research. The compendium also provides details of the active components, clinical benefits and other information about the company's dermatology products.
European Specialist in Veterinary Dermatology Filippo de Bellis said: "Dermatological problems can cause frustration to both clinician and pet owners because of their chronic nature and the wide variety of aetiologies. Best practice is achieved by integrating clinical expertise with the best external evidence.
"Virbac has made a major contribution to the provision of evidence by publishing this Compendium containing scientific information to support its range of pharmaceutical products. It shows commitment to the veterinary profession and to the rule of evidence-based medicine."
Christelle Navarro, DVM, from the Medical Department at Virbac SA, added: "We have spent 30 years working to improve veterinary dermatology with innovative solutions for the profession. Given the complexity of dermatology and the multiplicity of therapeutic offerings, we hope the Compendium will be a helpful tool for clinicians seeking scientific support for the products they use."
Electronic copies of the Compendium are available on request from your Territory Manager or by calling Virbac direct on 01359 243243.
Rimifin (carprofen), an NSAID marketed by Vetoquinol, has been given a new flavour to help increase compliance.
Robert Simpson, Product Manager for Rimifin said: "Pet owner compliance and involvement in chronic pain situations is critical to ensuring effective long term treatment. Ease of administration is also very important in this setting. The addition of this flavouring to this popular and cost effective NSAID will help to ensure that administration to the patient is as easy as possible for pet owners and vets."
To find out more about Rimifin please contact your Vetoquinol Territory Manager or call 01280 825424.
Virbac has launched an iPhone app designed to support veterinary surgeons in the diagnosis of canine dermatological conditions.
Called Virbac-Derm-Diag it enables clinicians to create a clinical history (including photographs) of a patient then recommends a clinical chronological approach for the diagnosis of many of the canine skin diseases seen most commonly in practice. It also contains a library of downloadable monographs, videos and images of skin diseases which can be used to support discussions with owners about diagnosis and potential treatment regimes.
Chris Geddes MRCVS, Product Manager, said: "Dog skin disorders are among the most common health problems seen in practice and have a wide range of causative factors. We are really excited about the launch of the app, which should prove really useful as vets work through the various steps of history-taking and examination required to reach an accurate diagnosis.
It also provides a wealth of materials to help them explain the implications of diagnosis to owners and recommended treatment options."
Veterinary dermatologist Anthony Chadwick said: "This is an ideal app for those vets who have an interest in dermatology and want readily accessible information at their fingertips. The images of lesions are likely to be particularly helpful."
Virbac Derm-Diag, it is available by searching for 'Virbac' in the app store (or click here). The content is restricted to veterinary surgeons, who must register at www.virbacderm.com to gain an access code.
Virbac says an iPad version will be available within weeks and there are plans to launch the app on other platforms shortly.
The RCVS Disciplinary Committee has directed that the name of a Berkshire-based veterinary surgeon, previously convicted of four offences under the Animal Welfare Act 2006, should be removed from the RCVS Register of Veterinary Surgeons.
Dr Ohene-Gyan was convicted at Reading Magistrates Court on 13 June 2012 of offences involving causing unnecessary suffering to three dogs and a cat that he had treated whilst working at Woosehill Vets, Wokingham, between February and October 2011. These offences related to failing to provide adequate or appropriate veterinary care or treatment, or failure to investigate and address an animal's poor condition. He was sentenced to 21 weeks' imprisonment concurrently for each offence.
Dr Ohene-Gyan did not attend the one-day Disciplinary Committee hearing and was not represented, although College records showed that he was aware of the dates of the hearing, and had had opportunity to apply for an adjournment. In the absence of any known good reason for Dr Ohene-Gyan's non-attendance, the Committee concluded that it was in the interests of justice that the hearing go ahead.
In considering whether the Respondent's convictions made him unfit to practise as a veterinary surgeon, the Committee depended on the findings of the District Judge and the remarks she had made when sentencing. "I found as a matter of fact that some of your actions were taken simply to run up a bill for the owners of pets," she had said. "You were in a position of special responsibility, trusted by the owners of the animals to treat them appropriately and to alleviate their suffering. You ignored advice from staff. Several animals were affected by your cruel disregard of their welfare. Some of the cruelty arose due to your incompetence. You have demonstrated that you are not fit to be trusted with the care of animals."
The Disciplinary Committee Chairman, Professor Peter Lees, speaking on behalf of the Committee, said: "The Respondent's actions, motivated by financial gain, caused serious actual injury to the four animals over a prolonged period of time. Clients are entitled to expect that veterinary surgeons will treat animals in their care humanely and with respect, and make animal welfare their first priority. The Committee considers that the care described in the District Judge's findings demonstrated a total disregard for the professional responsibilities of a veterinary surgeon."
The Committee concluded that the removal of Dr Ohene-Gyan's name from the Register was the only appropriate and proportionate sanction in this case in order to protect the welfare of animals, maintain public confidence in the profession and uphold proper standards of conduct, and it directed the Registrar to do so.
The BSAVA reports that its Certificates in Medicine and Surgery have sold out in less than 5 minutes, beating the previous record of 20 minutes in their first year.
The Association says that whilst this is testament to the success and demand for its CPD, it is determined to find a way to avoid disappointing so many aspiring students - and after emergency talks over the weekend has decided to run a second intake of 30 students for each of the two programmes from January.
Dr Frances Barr, BSAVA's Academic Director, said: "Whilst we had only envisioned taking 30 new students onto each course this year, it quickly became clear that there is such a great appetite for this kind of accredited CPD in the profession right now. What a shame it would have been not to find a way to allow those ambitions to be fulfilled. So we are effectively going to run each programme twice in one year."
Quality control and sufficient student support is being met thanks to an overwhelming response from our teaching faculty and mentors. Dr Barr added: "BSAVA owes thanks to all those who lecture and work alongside our Certificate students. Without them we would not have been able to respond so quickly to this unprecedented demand".
The second programme will take place at two sites; BSAVA HQ in Gloucester, and the College of Animal Welfare in Huntingdon. Anyone who has not been able to take a place in the 2013 cohort will be offered priority registration for the 2014 in-take. For more information about BSAVA Certificates visit www.bsava.com or email administration@bsava.com.
Norbrook Laboratories has launched a ready-to-use suspension version of its Cefenil antibiotic.
Cefenil RTU (ceftiofur) is a 50mg/ml suspension for injection, indicated for cattle and swine.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Cefenil RTU is a broad spectrum injectable antibiotic offering fast and effective treatment of bacterial respiratory disease, foot rot and acute post-partum metritis in cattle as well as bacterial respiratory disease in swine. It offers a zero milk withhold and a 5-day meat withhold which is the shortest on the market."
Norbrook's Cefenil Powder and Solution for Injection has been available for a number of years for the treatment of cattle and swine. It has recently been indicated for the treatment of BRD in horses in the UK. Cefenil RTU will offer vets an additional choice in the treatment of BRD.
Dr McInerney added: "Cefenil is a tried and tested antibiotic which vets have been using for a number of years. We are delighted to extend the Cefenil range with a RTU suspension for cattle and pigs and adding an indication for horses to our Cefenil Powder and Solution for Injection. It gives vets a wider choice for the treatment of BRD with a product with which they are already familiar."
For further product information, visit www.norbrook.com.
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one tablet which provides "dual blockade" of the RAAS system.
Benazepril reduces the production of angiotensin II, which causes narrowing of the blood vessels, while spironolactone blocks the harmful effects of aldosterone, which include cardiovascular remodelling and fibrosis.
Cardalis tablets are small, beef flavoured and designed to be administered once a day with food. Each pot contains 30 tablets and there are three sizes available. Ceva says it should be given as part of standard heart failure therapy as soon as clinical signs, such as exercise intolerance, coughing or dyspnoea, appear.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Through our clinical studies, it has been found that dogs receiving benazepril and spironolactone (compared with benazepril alone) have a better quality of life and, at any one time, are three times less likely to die from heart failure.
"We have also assessed 101 dogs in a field study that were prescribed Cardalis for three months, followed by separate benazepril and spironolactone tablets for two weeks. In the study, 97 per cent of dog owners found Cardalis easier to administer than the two separate tablets and 89 per cent of vets found Cardalis easier to prescribe."
For further information about Cardalis, or to receive marketing materials for the product (which include a waiting room poster and client information booklets), visit www.ceva.com.uk, or contact the practice support team on 01494 781510.
The badger culls planned to take place in West Somerset and West Gloucestershire this year have been postponed until 2013.
The postponement came at the request of The National Farmers Union (NFU), following new survey results which revealed higher than anticipated badger numbers in the two pilot areas (4,300 in West Somerset and 3,600 in West Gloucestershire ).
The NFU informed Defra that in light of these new figures they could not be confident of removing the required minimum 70% of the badgers in the two pilot areas this autumn.
Defra agreed to postpone the pilot culls until summer 2013 to allow farmers to continue their preparations and have the best possible chance of carrying out the cull effectively.
Environment Secretary Owen Paterson said: "Despite a greatly increased effort over the last few days and weeks, the farmers delivering this policy have concluded that they cannot be confident that it will be possible to remove enough badgers based on these higher numbers and considering the lateness of the season. It would be wrong to go ahead if those on the ground cannot be confident of removing at least 70% of the populations. Today I have received a letter from the President of the NFU, on behalf of the companies coordinating the culls, explaining why they do not feel they can go ahead this year and requesting that they be postponed until next summer. In these circumstances, it is the right thing to do and, as the people who have to deliver this policy on the ground and work within the science, I respect their decision.
"The Government is determined to tackle bovine TB by all the means available to us. Now, in the next few months, we will ensure that the pilot culls can be implemented effectively, in the best possible conditions, with the right resources. Having looked at all the evidence over many years, I am utterly convinced that badger control is the right thing to do, and indeed the higher than expected badger numbers only serve to underline the need for urgent action. I remain fully committed to working with the farming industry to ensure that the pilot culls can be delivered effectively, safely and humanely next summer."
The Government and NFU say they will now continue to plan so that the pilots can go ahead in Summer 2013.
Ceva Animal Health has launched Cystease Advanced, a new urinary tract support supplement for cats.
The new product, which contains N-acetyl glucosamine, L-tryptophan and Hyaluronic Acid, is described as an elaboration on the original product, Cystease S.
Ceva says Cystease Advanced has been designed to help support the bladder lining while also reducing stress-related behaviour in cats.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "It is well documented that stress can adversely affect the integrity of the bladder lining. There are many factors that cause stress in cats, for example inter-cat conflict, moving house, new arrivals to the home environment and car travel, to name just a few.
"Our new product has been developed to address both conditions; it contains N-acetyl glucosamine and Hyaluronic Acid which are key components of the GAG lining, whereas L-tryptophan has been proven to reduce stress-related behaviour in cats."
Cystease Advanced is taken orally and is available in pots of 30 and 300 tablets.
Ceva recommends that Cystease Advanced is used with Feliway, the company's appeasing pheromone for cats.
For further details please contact the customer support team on 01494 781510.